23andMe’s Personal Genome Service and Health Kit

June 2014: A federal judge granted the company’s motion to compel all of the plaintiffs in related cases to arbitrate their claims and dismissed plaintiffs’ claims When a complaint is dismissed without prejudice, an amended version of the complaint can be refiled.. For more information about the status, click here.

January 2014: A class-action lawsuit was filed against 23andMe, Inc. for allegedly falsely advertising its Personal Genome Service and Health Kit. Specifically, plaintiffs claim that the company represents that the Health Kit will provide consumers with information about their health – including “reports on over 240+ health conditions and traits” – without clinical data to support such claims. In addition, the complaint alleges that the company’s advertising of the Health Kit violates the Federal Food, Drug, and Cosmetic Act because the company did not obtain the necessary authorization from the FDA before marketing it. (Stanton et al v. 23andMe, Inc., Case No. 14-cv-00294, N. D. CA.).

For more information about other class-action lawsuits filed against 23andMe and TINA.org’s coverage of the company, click here.